Industry Analysis & Industry Trends
In 2012, revenue for the Pharmaceutical Manufacturing industry is expected to total $78.8 billion, up 16.3% from 2011. This represents an annualized growth rate of 22.1% since 2007. The industry's profitability has also been increasing – from 10.2% of industry revenue in 2007 to 10.8% in 2012. There are about 1,360 industry enterprises in 2012, employing about 567,816 people with a payroll of about $5.0 billion.
Hospitals are currently the main distribution channel for medicines produced by this industry. However, upcoming healthcare reforms will enable drugstores to become the major distribution channel in the near future. In the past, many consumers could not afford to purchase medicine or see a doctor.... purchase to read more
Industry Report - Industry Analysis Chapter
Revenue for the Pharmaceutical Manufacturing industry is expected to increase at an annualized rate of 22.1% in the five years to 2012 to reach $78.8 billion. Growth has been largely driven by rising market demand and the rising income levels of consumers.
Industry profitability had been stable for a number of years, before increasing in 2007 and in 2008. In 2009, with the implementation of the national essential medicine system in China and decreasing foreign demand, industry profit declined. Though the price of basic medicine is still under strict control, manufacturers are focusing more on products with higher profit, thus profitability is expected to reach 10.8% in 2012. The increased profit margin is also due to companies controlling costs and improving productivity... purchase to read more